Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Burning Rock Biotech Limited Sponsored ADR (BNR : NSDQ)

• Company Description    Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is based in GUANGZHOU, China. Number of Employees: 674

• Price / Volume Information    Yesterday's Closing Price: $3.98 Daily Weekly Monthly 20 Day Moving Average: 17,622 shares Shares Outstanding: 10.76 (millions) Market Capitalization: $42.83 (millions) Beta: 0.75 52 Week High: $7.90 52 Week Low: $2.18 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.24% -4.94% 12 Week 42.14% 19.56% Year To Date -41.04% -44.78%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL NO. 5 XINGDAO RING ROAD NORTH INTERNATIONAL BIO ISLAND - GUANGZHOU GUANGDONG,F4 510005 CHN ph: 86-185-0164-1666 fax: - ir@brbiotech.com http://www.brbiotech.com

• General Corporate Information    Officers Yusheng Han - Founder; chairman of the board of directors and ch Xiaozhi Hu - Senior director in finance Gang Lu - Director Feng Deng - Director Feng Deng - Director Peer Information Burning Rock Biotech Limited Sponsored ADR (EVOL) Burning Rock Biotech Limited Sponsored ADR (RAMP) Burning Rock Biotech Limited Sponsored ADR (LGTY) Burning Rock Biotech Limited Sponsored ADR (ALOT) Burning Rock Biotech Limited Sponsored ADR (CXT) Burning Rock Biotech Limited Sponsored ADR (TGHI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 12233L206 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/28/25 Share - Related Items Shares Outstanding: 10.76 Most Recent Split Date: 5.00 (0.10:1) Beta: 0.75 Market Capitalization: $42.83 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/28/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.54 Price/Cash Flow: - Price / Sales: 0.59 EPS Growth vs. Year Ago Period: -6.25% vs. Previous Quarter: 84.26% Sales Growth vs. Year Ago Period: 5.41% vs. Previous Quarter: 6.23% ROE 06/30/25 - - 03/31/25 - -38.33 12/31/24 - -52.60 ROA 06/30/25 - - 03/31/25 - -25.34 12/31/24 - -35.58 Current Ratio 06/30/25 - - 03/31/25 - 3.02 12/31/24 - 2.92 Quick Ratio 06/30/25 - - 03/31/25 - 2.76 12/31/24 - 2.68 Operating Margin 06/30/25 - - 03/31/25 - -45.41 12/31/24 - -66.90 Net Margin 06/30/25 - - 03/31/25 - -45.41 12/31/24 - -66.90 Pre-Tax Margin 06/30/25 - - 03/31/25 - -43.68 12/31/24 - -66.06 Book Value 06/30/25 - - 03/31/25 - 7.32 12/31/24 - 7.39 Inventory Turnover 06/30/25 - - 03/31/25 - 2.26 12/31/24 - 2.35 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©